Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacology of levodopa/carbidopa versus levodopa/benserazide in Parkinson's disease
ChiCTR2000039201Phase 4Recruiting
- Sponsor
- Affiliated Brain Hospital of Nanjing Medical University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of levodopa, carbidopa and benserazide in Parkinson's disease (PD) (2 arms), sponsored by Affiliated Brain Hospital of Nanjing Medical University. Primary endpoints: Levodopa plasma concentration, Carbidopa plasma concentration and 3 more. Started Dec 2020; status: recruiting.
02
Drugs
levodopacarbidopabenserazide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on ChiCTR2000039201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039201.